370 related articles for article (PubMed ID: 20634576)
1. Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein.
Singh M; Dang TN; Arseneault M; Ramassamy C
J Alzheimers Dis; 2010; 21(3):741-56. PubMed ID: 20634576
[TBL] [Abstract][Full Text] [Related]
2. Potential role of acrolein in neurodegeneration and in Alzheimer's disease.
Dang TN; Arseneault M; Murthy V; Ramassamy C
Curr Mol Pharmacol; 2010 Jun; 3(2):66-78. PubMed ID: 20302565
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease.
Williams TI; Lynn BC; Markesbery WR; Lovell MA
Neurobiol Aging; 2006 Aug; 27(8):1094-9. PubMed ID: 15993986
[TBL] [Abstract][Full Text] [Related]
4. Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD.
Reed TT; Pierce WM; Markesbery WR; Butterfield DA
Brain Res; 2009 Jun; 1274():66-76. PubMed ID: 19374891
[TBL] [Abstract][Full Text] [Related]
5. Modulation of hydrogen peroxide and acrolein-induced oxidative stress, mitochondrial dysfunctions and redox regulated pathways by the Bacopa monniera extract: potential implication in Alzheimer's disease.
Singh M; Murthy V; Ramassamy C
J Alzheimers Dis; 2010; 21(1):229-47. PubMed ID: 20421692
[TBL] [Abstract][Full Text] [Related]
6. Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment.
Markesbery WR; Kryscio RJ; Lovell MA; Morrow JD
Ann Neurol; 2005 Nov; 58(5):730-5. PubMed ID: 16240347
[TBL] [Abstract][Full Text] [Related]
7. Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment.
Butterfield DA; Reed T; Perluigi M; De Marco C; Coccia R; Cini C; Sultana R
Neurosci Lett; 2006 Apr; 397(3):170-3. PubMed ID: 16413966
[TBL] [Abstract][Full Text] [Related]
8. Oxidative damage in mild cognitive impairment and early Alzheimer's disease.
Lovell MA; Markesbery WR
J Neurosci Res; 2007 Nov; 85(14):3036-40. PubMed ID: 17510979
[TBL] [Abstract][Full Text] [Related]
9. Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease.
Calingasan NY; Uchida K; Gibson GE
J Neurochem; 1999 Feb; 72(2):751-6. PubMed ID: 9930749
[TBL] [Abstract][Full Text] [Related]
10. Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.
Reed T; Perluigi M; Sultana R; Pierce WM; Klein JB; Turner DM; Coccia R; Markesbery WR; Butterfield DA
Neurobiol Dis; 2008 Apr; 30(1):107-20. PubMed ID: 18325775
[TBL] [Abstract][Full Text] [Related]
11. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease.
Padurariu M; Ciobica A; Hritcu L; Stoica B; Bild W; Stefanescu C
Neurosci Lett; 2010 Jan; 469(1):6-10. PubMed ID: 19914330
[TBL] [Abstract][Full Text] [Related]
12. Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease.
Butterfield DA; Bader Lange ML; Sultana R
Biochim Biophys Acta; 2010 Aug; 1801(8):924-9. PubMed ID: 20176130
[TBL] [Abstract][Full Text] [Related]
13. Lipid oxidation and modification of amyloid-β (Aβ) in vitro and in vivo.
Ellis G; Fang E; Maheshwari M; Roltsch E; Holcomb L; Zimmer D; Martinez D; Murray IV
J Alzheimers Dis; 2010; 22(2):593-607. PubMed ID: 20847409
[TBL] [Abstract][Full Text] [Related]
14. Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures.
Lovell MA; Xie C; Markesbery WR
Free Radic Biol Med; 2000 Oct; 29(8):714-20. PubMed ID: 11053772
[TBL] [Abstract][Full Text] [Related]
15. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death.
Butterfield DA; Castegna A; Lauderback CM; Drake J
Neurobiol Aging; 2002; 23(5):655-64. PubMed ID: 12392766
[TBL] [Abstract][Full Text] [Related]
16. Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures.
Lovell MA; Xie C; Markesbery WR
Neurobiol Aging; 2001; 22(2):187-94. PubMed ID: 11182468
[TBL] [Abstract][Full Text] [Related]
17. Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease.
Dei R; Takeda A; Niwa H; Li M; Nakagomi Y; Watanabe M; Inagaki T; Washimi Y; Yasuda Y; Horie K; Miyata T; Sobue G
Acta Neuropathol; 2002 Aug; 104(2):113-22. PubMed ID: 12111353
[TBL] [Abstract][Full Text] [Related]
18. Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases.
Montine KS; Quinn JF; Zhang J; Fessel JP; Roberts LJ; Morrow JD; Montine TJ
Chem Phys Lipids; 2004 Mar; 128(1-2):117-24. PubMed ID: 15037157
[TBL] [Abstract][Full Text] [Related]
19. Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders.
Di Domenico F; Tramutola A; Butterfield DA
Free Radic Biol Med; 2017 Oct; 111():253-261. PubMed ID: 27789292
[TBL] [Abstract][Full Text] [Related]
20. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
